Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05612750 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

A NA study of Pain, Chronic and Pelvic Pain, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
1,650
Enrollment target
5
Study locations

NCT05612750: Recruiting NA study of Pain, Chronic and Pelvic Pain, sponsored by Stanford University.

NCT05612750 is a NA study of Pain, Chronic and Pelvic Pain that is actively recruiting participants, run by Stanford University. The registered enrollment target is 1,650 participants, above the 687-participant average among 48 other Pain, Chronic trials with a reported enrollment target (140% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05612750, a NA study of Pain, Chronic and Pelvic Pain, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
1,650 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to conduct a pragmatic clinical trial comparing the effectiveness of: (1) 8-week cognitive behavioral therapy for chronic pain (pain-CBT; sixteen hours total treatment time); and (2) a 1-session pain relief skills intervention for chronic pain (Empowered Relief; two hours total treatment time).

Primary Outcome

Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10)

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Empowered Relief

Study Locations (5)

Arizona

  • Phoenix VA Health Care System - Phoenix

California

  • SCAN Health Plan - Long Beach

Kentucky

  • Humana - Louisville

Pennsylvania

  • Lehigh Valley Health Network - Allentown

Utah

  • Intermountain Healthcare - Salt Lake City

Trial Details

FieldValue
Enrollment Target 1,650 participants
Start Date 2023-01-01
Est. Completion 2029-05-01
Phase NA
Stanford University

1,744 total trials

What NCT05612750 shows while recruiting

NCT05612750 is an interventional study that assigns participants to a tested intervention. Its 1,650 participants enrollment target places it among the larger protocols in the corpus, above the 687-participant average among 48 other Pain, Chronic trials with a reported enrollment target (140% higher).

The record links to 3 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT05612750 lists 5 locations in 5 states (Arizona, California, Kentucky).

Frequently Asked Questions

What is clinical trial NCT05612750 about?

NCT05612750 is a clinical study titled "Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study". The purpose of this study is to conduct a pragmatic clinical trial comparing the effectiveness of: (1) 8-week cognitive behavioral therapy for chronic pain (pain-CBT; sixteen hours total treatment time); and (2) a 1-session pain relief skills intervention for chronic pain (Empowered Relief; two hour...

What is the current status of trial NCT05612750?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,650 participants. The study started on 2023-01-01. Estimated completion is 2029-05-01.

What conditions does trial NCT05612750 study?

This clinical trial studies the following conditions: Pain, Chronic, Pelvic Pain, Lupus.

What interventions are being tested in trial NCT05612750?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Empowered Relief (BEHAVIORAL).

Who is sponsoring clinical trial NCT05612750?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05612750 being conducted?

This trial has 5 study locations across Arizona, California, Kentucky, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05612750's enrollment target sits among peer trials

1,650 3rd of 48 higher than 46 of 48 other Pain, Chronic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04510129 · 1,650 participants

    A Multicenter Cancer Biospecimen Collection Study

  • NCT06215716 · 1,650 participants · Phase 3

    A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

  • NCT07046260 · 1,650 participants

    Prospective Study to Assess a Diagnostic Aid for Cancer

  • NCT06401330 · 1,656 participants · Phase 3

    A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05612750, the US trial registry maintained by the National Library of Medicine. NCT05612750 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.